These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34858331)
1. MIA SH3 Domain ER Export Factor 3 Deficiency Prevents Neointimal Formation by Restoring BAT-Like PVAT and Decreasing VSMC Proliferation and Migration. Lei Y; Xu J; Li M; Meng T; Chen M; Yang Y; Li H; Zhuang T; Zuo J Front Endocrinol (Lausanne); 2021; 12():748216. PubMed ID: 34858331 [TBL] [Abstract][Full Text] [Related]
2. Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells. Aherrahrou R; Guo L; Nagraj VP; Aguhob A; Hinkle J; Chen L; Yuhl Soh J; Lue D; Alencar GF; Boltjes A; van der Laan SW; Farber E; Fuller D; Anane-Wae R; Akingbesote N; Manichaikul AW; Ma L; Kaikkonen MU; Björkegren JLM; Önengüt-Gümüşcü S; Pasterkamp G; Miller CL; Owens GK; Finn A; Navab M; Fogelman AM; Berliner JA; Civelek M Circ Res; 2020 Dec; 127(12):1552-1565. PubMed ID: 33040646 [TBL] [Abstract][Full Text] [Related]
3. OCT4 regulated neointimal formation in injured mouse arteries by matrix metalloproteinase 2-mediated smooth muscle cells proliferation and migration. Ding X; Yan Y; Zhang C; Xu X; Yang F; Liu Y; Wang G; Qin Y J Cell Physiol; 2021 Jul; 236(7):5421-5431. PubMed ID: 33372301 [TBL] [Abstract][Full Text] [Related]
4. Vascular injury activates the ELK1/SND1/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia. Su C; Liu M; Yao X; Hao W; Ma J; Ren Y; Gao X; Xin L; Ge L; Yu Y; Wei M; Yang J Cell Mol Life Sci; 2024 Jan; 81(1):59. PubMed ID: 38279051 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor. Zhang J; Zou F; Tang J; Zhang Q; Gong Y; Wang Q; Shen Y; Xiong L; Breyer RM; Lazarus M; Funk CD; Yu Y Circ Res; 2013 Jul; 113(2):104-14. PubMed ID: 23595951 [TBL] [Abstract][Full Text] [Related]
6. Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia. Ko DS; Kang J; Heo HJ; Kim EK; Kim K; Kang JM; Jung Y; Baek SE; Kim YH Int J Biol Sci; 2022; 18(13):5154-5167. PubMed ID: 35982907 [TBL] [Abstract][Full Text] [Related]
7. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration. Chen Q; Yang F; Guo M; Wen G; Zhang C; Luong le A; Zhu J; Xiao Q; Zhang L J Mol Cell Cardiol; 2015 Dec; 89(Pt A):75-86. PubMed ID: 26493107 [TBL] [Abstract][Full Text] [Related]
8. IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury. Kohno T; Urao N; Ashino T; Sudhahar V; Inomata H; Yamaoka-Tojo M; McKinney RD; Fukai T; Ushio-Fukai M Am J Physiol Cell Physiol; 2013 Sep; 305(6):C591-600. PubMed ID: 23657573 [TBL] [Abstract][Full Text] [Related]
9. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation. Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750 [TBL] [Abstract][Full Text] [Related]
15. Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury. Pellet-Many C; Mehta V; Fields L; Mahmoud M; Lowe V; Evans I; Ruivo J; Zachary I Cardiovasc Res; 2015 Nov; 108(2):288-98. PubMed ID: 26410366 [TBL] [Abstract][Full Text] [Related]
16. Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells. Yu Y; Li Y; Peng H; Song Q; Da X; Li H; He Z; Ren X; Xu C; Yao Y; Wang QK J Biol Chem; 2022 Apr; 298(4):101759. PubMed ID: 35202649 [TBL] [Abstract][Full Text] [Related]
17. Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models. Chappell J; Harman JL; Narasimhan VM; Yu H; Foote K; Simons BD; Bennett MR; Jørgensen HF Circ Res; 2016 Dec; 119(12):1313-1323. PubMed ID: 27682618 [TBL] [Abstract][Full Text] [Related]
18. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype. Cao T; Zhang L; Yao LL; Zheng F; Wang L; Yang JY; Guo LY; Li XY; Yan YW; Pan YM; Jiang M; Chen L; Tang JM; Chen SY; Wang JN Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2772-2782. PubMed ID: 28693920 [TBL] [Abstract][Full Text] [Related]
19. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of thrombospondin-2 alleviates intimal hyperplasia in mice by modulating vascular smooth muscle cell proliferation and migration. Li X; Ding Y; Zhou M; Zhou Z; Xie T; Wang Y; Liu Z; Si Y; Shi Z FASEB J; 2023 Feb; 37(2):e22743. PubMed ID: 36645109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]